Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 217

1.

Current and Future Perspectives on Skin Tissue Engineering: Key Features of Biomedical Research, Translational Assessment, and Clinical Application.

Yu JR, Navarro J, Coburn JC, Mahadik B, Molnar J, Holmes JH 4th, Nam AJ, Fisher JP.

Adv Healthc Mater. 2019 Feb 1:e1801471. doi: 10.1002/adhm.201801471. [Epub ahead of print] Review.

PMID:
30707508
2.

Common hydrotherapy practices and the prevalence of burn wound bacterial colonisation at the University Teaching Hospital in Lusaka, Zambia.

Ziwa M, Jovic G, Ngwisha CLT, Molnar JA, Kwenda G, Samutela M, Mulowa M, Kalumbi MM.

Burns. 2018 Dec 27. pii: S0305-4179(18)30307-3. doi: 10.1016/j.burns.2018.11.019. [Epub ahead of print]

PMID:
30595542
3.

Benzoxazole-based Zn(II) and Cu(II) Complexes Overcome Multidrug-resistance in Cancer.

Spengler G, Kincses A, Rácz B, Varga B, Watanabe G, Saijo R, Sekiya H, Tamai E, Maki J, Molnár J, Kawase M.

Anticancer Res. 2018 Nov;38(11):6181-6187. doi: 10.21873/anticanres.12971.

PMID:
30396935
4.

Terpenoids from Euphorbia pedroi as Multidrug-Resistance Reversers.

Ferreira RJ, Kincses A, Gajdács M, Spengler G, Dos Santos DJVA, Molnár J, Ferreira MU.

J Nat Prod. 2018 Sep 28;81(9):2032-2040. doi: 10.1021/acs.jnatprod.8b00326. Epub 2018 Sep 10.

PMID:
30199257
5.

In Vitro Evaluation of the Multidrug Resistance Reversing Activity of Novel Imidazo[4,5-b]pyridine Derivatives.

Bourichi S, Misbahi H, Rodi YK, Chahdi FO, Essassi EM, Szabó S, Szalontai B, Gajdács M, Molnár J, Spengler G.

Anticancer Res. 2018 Jul;38(7):3999-4003. doi: 10.21873/anticanres.12687.

PMID:
29970523
6.

Amyloid-beta Interactions with ABC Transporters and Resistance Modifiers.

Molnar J, Ocsovszki I, Pusztai R.

Anticancer Res. 2018 Jun;38(6):3407-3410. doi: 10.21873/anticanres.12608.

PMID:
29848690
7.

A Comparative Study of the ReCell® Device and Autologous Spit-Thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries.

Holmes Iv JH, Molnar JA, Carter JE, Hwang J, Cairns BA, King BT, Smith DJ, Cruse CW, Foster KN, Peck MD, Sood R, Feldman MJ, Jordan MH, Mozingo DW, Greenhalgh DG, Palmieri TL, Griswold JA, Dissanaike S, Hickerson WL.

J Burn Care Res. 2018 Aug 17;39(5):694-702. doi: 10.1093/jbcr/iry029.

8.

Multidrug resistance reversal activity of extract and a rare dimeric naphthoquinone from Diospyros lotus.

Rauf A, Shaheen U, Raza M, Uddin G, Hadda TB, Mabkhot YN, Jehan N, Ahmad B, Raza S, Molnar J, Csonka Á, Szabó D.

Pak J Pharm Sci. 2018 May;31(3):821-825.

PMID:
29716861
9.

Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis.

Lentz F, Reiling N, Martins A, Molnár J, Hilgeroth A.

Molecules. 2018 Apr 4;23(4). pii: E825. doi: 10.3390/molecules23040825.

10.

Extensive Hand Thermal and Blast Injury From Electronic Cigarette Explosion: A Case Report.

Satteson ES, Walker NJ, Tuohy CJ, Molnar JA.

Hand (N Y). 2017 Nov 1:1558944717744333. doi: 10.1177/1558944717744333. [Epub ahead of print]

PMID:
29192506
11.

Possible Biological and Clinical Applications of Phenothiazines.

Varga B, Csonka Á, Csonka A, Molnár J, Amaral L, Spengler G.

Anticancer Res. 2017 Nov;37(11):5983-5993. Review.

PMID:
29061777
12.

Trigger Thumb.

Pencle FJ, Molnar JA.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Oct 27.

13.

Isolation of Chlorogenic Acid from Soil Borne Fungi Screlotium rolfsii, their Reversal of Multidrug Resistance and Anti-proliferative in Mouse Lymphoma Cells.

Ahmad B, Rizwan M, Rauf A, Raza M, Bashir S, Molnar J, Csonka A, Szabo D, Mubarak MS, Noor M, Siddiqui BS.

Med Chem. 2017;13(8):721-726. doi: 10.2174/1573406413666170612110443.

PMID:
28606042
14.

Synthesis and SAR Study of Anticancer Protoflavone Derivatives: Investigation of Cytotoxicity and Interaction with ABCB1 and ABCG2 Multidrug Efflux Transporters.

Dankó B, Tóth S, Martins A, Vágvölgyi M, Kúsz N, Molnár J, Chang FR, Wu YC, Szakács G, Hunyadi A.

ChemMedChem. 2017 Jun 7;12(11):850-859. doi: 10.1002/cmdc.201700225. Epub 2017 May 23.

PMID:
28436164
15.

Exploring Jolkinol D Derivatives To Overcome Multidrug Resistance in Cancer.

Reis MA, Ahmed OB, Spengler G, Molnár J, Lage H, Ferreira MU.

J Nat Prod. 2017 May 26;80(5):1411-1420. doi: 10.1021/acs.jnatprod.6b01084. Epub 2017 Apr 19.

PMID:
28421773
16.

Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells.

Paterna A, Kincses A, Spengler G, Mulhovo S, Molnár J, Ferreira MU.

Eur J Med Chem. 2017 Mar 10;128:247-257. doi: 10.1016/j.ejmech.2017.01.044. Epub 2017 Feb 1.

PMID:
28189906
17.

Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition.

Hunyadi A, Csábi J, Martins A, Molnár J, Balázs A, Tóth G.

Molecules. 2017 Jan 25;22(2). pii: E199. doi: 10.3390/molecules22020199.

18.

Fluorinated Beta-diketo Phosphorus Ylides Are Novel Efflux Pump Inhibitors in Bacteria.

Kincses A, Szabó ÁM, Saijo R, Watanabe G, Kawase M, Molnár J, Spengler G.

In Vivo. 2016 11-12;30(6):813-817.

PMID:
27815466
19.

The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug Thioridazine.

Spengler G, Csonka Á, Molnár J, Amaral L.

Anticancer Res. 2016 Nov;36(11):5701-5706. Review.

PMID:
27793891

Supplemental Content

Loading ...
Support Center